Ownership
Private
Employees
~15
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved

NexGen Biobanking General Information

NexGen Biobanking is a College of American Pathologists (CAP) accredited biorepository founded in 2019. It provides comprehensive specimen management, storage, processing, and logistics solutions for academic institutions, pharmaceutical companies, biotechnology firms, government agencies, and healthcare organizations. The company's state-of-the-art facilities offer secure storage for blood, tissue, DNA/RNA samples, cell lines and more at various temperature ranges including cryogenic conditions. Its leadership team brings over a century of combined experience in repository operations and biospecimen management.

Contact Information

Primary Industry
Drug Discovery Services
Corporate Office
Norcross, Georgia
United States

Drug Pipeline

No pipeline data available

For full access to NexGen Biobanking's pipeline data

Book a demo

Key Partnerships

Center for Global Health Innovation (collaborative relationship)

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

NexGen Biobanking Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view NexGen Biobanking's complete valuation and funding history, request access »

NexGen Biobanking Financial Metrics